Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01158 |
| Species: | Homo sapiens |
| Position : | chr11:118559857-118561857 |
| Year: | 2015 |
| Title: | Functional analysis of the 11q23.3 glioma susceptibility locus implicates PHLDB1 and DDX6 in glioma susceptibility. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | malignant glioma |
| PMID: | 26610392 |
| MONDO: | MONDO:0100342 |
| Tissue: | brain |
| Tissue Ontology ID: | UBERON:0000955 |
| Cell Source: | U-87MG ATCC |
| CVCL ID: | CVCL_0022 |
| Cell Type: | glioblastoma-like cell line |
| Experiment Type: | Enhancer activity assay; Allele-specific functional assay; Chromatin interaction assay; Functional perturbation assay |
| High Throughput Method: | ENCODE H3K27ac/H3K4me1/H3K4me3/DHS/FAIRE-seq integration; RNA polymerase II ChIA-PET data integration; 3C |
| Low Throughput Method: | Luciferase enhancer scanning; allele-specific reporter assay; EMSA; 3C; DDX6 siRNA knockdown; RT-qPCR; neurosphere formation assay; Luciferase reporter assay |
| Target gene : | DDX6 |
| TF name : | NA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|